Empirical treatment of granulomatous hepatitis of unknown origin: practice investigation in the french national society of internal medicine;Traitement d'épreuve d'une hépatite granulomateuse symptomatique de cause indéterminée : enquête de pratique au sein de la Société nationale française de médecine interne

Revue de Medecine Interne

Volumn 27, Issue 4, 2006, Pages 276-284

  Agard, C ^a   Pottier, P ^a   Hamidou, M ^a   Papo, T ^b   Genereau T ^c   de Faucal, P ^c   Boutoille, D ^a   Ponge, T ^a   Connault, J ^a   Brisseau, J M ^a   Planchon, B ^a   Barrier, J H ^a  

^a HÔTEL DIEU   (France)

^b BICHAT HOSPITAL   (France)

^c Service de médecine interne   (France)

Author keywords

Empirical treatment; Granulomatous hepatitis; Sarcoidosis; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; DOXYCYCLINE; ETHAMBUTOL; ISONIAZID; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BODY WEIGHT; DRUG EFFICACY; FEVER; GRANULOMATOUS HEPATITIS; HEALTH CARE ORGANIZATION; HUMAN; IDIOPATHIC DISEASE; MEDICAL SOCIETY; MEDICAL SPECIALIST; MEDICAL STUDENT; PRESCRIPTION; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT FAILURE;

ADRENAL CORTEX HORMONES; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTITUBERCULAR AGENTS; BIOPSY; DRUG THERAPY, COMBINATION; FRANCE; GRANULOMA; HEPATITIS; HEPATOMEGALY; HUMANS; INTERNAL MEDICINE; LIVER; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PREDNISONE; QUESTIONNAIRES; SOCIETIES, MEDICAL; TIME FACTORS; TUBERCULOMA;

EID: 33646475720     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.01.005     Document Type: Article

References (28)

1. Cunningham D., Mills P.R., Quigley E.M.M., Patrick R.S., Watkinson G., MacKenzie J.F., et al. Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q. J. Med. 51 202 (1982) 162-170
2. Harrington P.T., Guttierez J.J., Ramirez-Ronda C.H., Quinones-Soto R., Bermudez R.H., and Chaffey J. Granulomatous hepatitis. Rev. Infect. Dis. 4 3 (1982) 638-655
3. McCluggage W.G., and Sloan J.M. Hepatic granulomas in Northern Ireland: a thirteen years review. Histopathology 25 (1994) 219-228
4. Valla D.C., and Benhamou J.P. Hepatic granulomas and hepatic sarcoidosis. Clin. Liver Dis. 4 1 (2000) 269-285
5. Gaya D.R., Thorburn D., Oien K.A., Morris A.J., and Stanley A.J. Hepatic granulomas: a 10 years single centre experience. J. Clin. Pathol. 56 (2003) 850-853
6. Matheus T., and Muñoz S. Granulomatous liver disease and cholestasis. Clin. Liver Dis. 8 (2004) 229-246
7. Papo T., and Piette J.C. Granulomatoses systémiques (2000), Flammarion Médecine-Science, Paris
8. Degos F. Granulomatoses hépatiques d'origine infectieuse. Rev. Prat. 51 19 (2001) 2075-2080
9. Telenti A., and Hermans P.E. Idiopathic granulomatosis manifesting as fever of unknown origin. Mayo Clin. Proc. 64 (1989) 44-50
10. Knox T.A., Kaplan M.M., Gelfand J.A., and Wolff S.M. Methotrexate treatment of idiopathic granulomatous hepatitis. Ann. Intern. Med. 122 8 (1995) 592-595
11. Knockaert D.C., Vanneste L.J., Vanneste S.B., and Bonnaers H.J. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch. Intern. Med. 152 (1992) 51-55
12. De Kleijn E.M.H.A., Van Lier H.J.J., Van Der Meer J.W.M., and the Netherlands FUO study group: Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. Medicine 76 6 (1997) 401-414
13. Arnow P.M., and Flaherty J.P. Fever of unknown origin. Lancet 350 (1997) 575-580
14. Tal S., Guller V., Gurevich A., and Levi S. Fever of unknown origin in the elderly. J. Intern. Med. 252 (2002) 295-304
15. Collazos J., Guerra E., Mayo J., and Martinez E. Tuberculosis as a cause of recurrent fever of unknown origin. J. Infect. 41 3 (2000) 269-272
16. Liu K.S., Sheng W.H., Chen Y.C., Chang S.C., and Hsieh W.C. Fever of unknown origin: a retrospective study of 78 adult patients in Taiwan. J. Microbiol. Immunol. Infect. 36 4 (2003) 243-247
17. De Kleijn E.M.H.A., Vandenbroucke J.P., Van Der Meer J.W.M., and the Netherlands FUO study group: Fever of unknown origin (FUO). I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine 76 6 (1997) 392-400
18. Knockaert D.C., Vanneste L.J., and Bobbaers H.J. Fever of unknown origin in elderely patients. J. Am. Geriatr. Soc. 41 11 (1993) 1187-1192
19. Knobel B., Buyanowsky G., Dan M., and Zaidel L. Pyrazinamide-induced granulomatous hepatitis. J. Clin. Gastroenterol. 24 4 (1997) 264-266
20. Crespo M., Sopena B., Bordon J., de la Fuente J., Rubianes M., and Martinez-Vasquez C. Steroids treatment of granulomatous hepatitis complicating Coxiella burnetii acute infection. Infection 27 2 (1999) 132-133
21. Voils S.A., Evans M.E., Lane M.T., Schosser R.H., and Rapp R.P. Use of macrolides and tetracyclines for chronic inflammatory diseases. Ann. Pharmacother. 39 1 (2005) 86-94
22. Bachelez H., Senet P., Cadranel J., Kaoukhov A., and Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch. Dermatol. 137 1 (2001) 69-73
23. Marshall T.G., and Marshall F.E. Sarcoidosis succumbs to antibiotics-implications for autoimmune disease. Autoimmun. Rev. 3 (2004) 295-300
24. Bonnetblanc J.M. Doxycycline. Ann. Dermatol. Venereol. 129 (2002) 874-882
25. Kloppenburg M., Verweij C.L., Miltenburg A.M., Verhoeven A.J., Daha M.R., Dijkmans B.A., et al. The influence of tetracyclines on T cell activation. Clin. Exp. Immunol. 102 3 (1995) 635-641
26. Webster G.F., Toso S.M., and Hegemann L. Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch. Dermatol. 130 6 (1994) 748-752
27. Valeyre D., Soler P., Tazi A., Brauner M., Chapelon-Abric C., Sadoun D., et al. Sarcoïdose (2000), Flammarion Médecine-Science, Paris
28. Barrier J., Roblot P., Ramassamy A., and Becq-Giraudon B. Le test à l'indométacine permet-il d'orienter le diagnostic étiologique d'une fièvre isolée ?. Rev. Med. Interne 16 (1995) 658-661